A pharmaceutical company, Pharmacy Plus has launched Duostam, an advanced treatment for Benign Prostatic Hyperplasia (BPH), also known as prostate enlargement.

Adjunct treatment with anastrozole in children with congenital adrenal hyperplasia (CAH) delays the rate of bone maturation and increases the predicted adult height over 6 years, with no significant ...

Benign prostatic hyperplasia (BPH) is a medical condition that most men experience as they age. BPH affects approximately 50% ...

Prostate Treatment Market. The global benign prostatic hyperplasia (BPH) prostate treatment market is set for consistent ...

Urological and fertility issues are common and treatable. Men need to prioritise their health by making lifestyle changes, ...

Pharmacy Plus, a leading pharmaceutical company, has launched Duostam, an advanced treatment for Benign Prostatic Hyperplasia ...

Britain's King Charles has been recently diagnosed with cancer while undergoing treatment for an enlarged prostate or benign prostatic hyperplasia. While the type and stage of malignancy still remains ...

Benign Prostatic Hyperplasia (BPH) is a common condition that affects many men as they age, causing the prostate to enlarge ...

SIMULTANEOUS endometrial aspiration and sonohysterography offer a highly sensitive screening approach for detecting ...

In its early stages, prostate cancer rarely causes noticeable symptoms. By the time warning signs like difficulty urinating ...

Prostatic artery embolization or PAE is a minimally invasive treatment that helps improve lower urinary tract symptoms caused ...